Showing results (131-140 of 223) with videos related to

Sort By:
Pageof 23
The Urologic Clinics of North America|November 1, 1993
Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trialH A Guess, J F Heyse, G J Gormley, et al.
The Journal of Urology|September 1, 1997
Update on the appropriate staging evaluation for newly diagnosed prostate cancerG J O'Dowd, R W Veltri, R Orozco, et al.
Archives of Internal Medicine|March 13, 1995
New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United StatesS J Jacobsen, C J Girman, H A Guess, et al.
The Journal of Urology|July 1, 1987
Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostateJ E Oesterling, C B Brendler, J I Epstein, et al.
Cancer|May 1, 1990
Advanced small cell carcinoma of the bladder. Successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapyJ E Oesterling, C B Brendler, J K Burgers, et al.
American Journal of Clinical Pathology|May 12, 1998
Serum percent-free PSA does not predict extraprostatic spread of prostate cancerW H Henricks, B G England, D A Giacherio, et al.
The Urologic Clinics of North America|November 1, 1993
Influence of patient age on the serum PSA concentration. An important clinical observationJ E Oesterling, W H Cooner, S J Jacobsen, et al.
Urology|April 1, 1997
Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary?M Goh, C G Kleer, P Kielczewski, et al.
Clinical Chemistry|October 1, 1987
Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay comparedD W Chan, D J Bruzek, J E Oesterling, et al.
The Journal of Urology|December 22, 1999
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serumC Becker, T Piironen, K Pettersson, et al.
Pageof 23